Trial | NCT04297358  Report issue

Title

Hyperbaric Oxygen in Patients Who Had a Stroke
Hyperbaric Oxygen Treatment in Chronic Stroke a Feasibility Study

  • Phase

    Phase 4

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    10
Prospective clinical assessment of 40 Hyperbaric Oxygen (HBO) treatments in 10 completed stroke patients.
10 patients having suffered a stroke and having being rehabilitated will be treated with 40 consecutive Hyperbaric Oxygen Treatment (HBOT) after a minimal delay of 3 months after stroke. They will be neurologically assessed before and 3 months after HBOT. Rivermead mobility index will be also assessed.
Study Started
Dec 20
2017
Primary Completion
Dec 30
2022
Study Completion
Dec 31
2022
Last Update
Mar 02
2023

Drug Hyperbaric oxygen

40 consecutive (5/7) sessions of hyperbaric oxygen

Stroke patients Experimental

40 consecutive sessions of hyperbaric oxygen will be administered at a pressure of 2 absolute atmosphere (ATA) to 10 patients. If there are drop outs, recruitment will be continued until a total of 10 patients with at least 30 sessions.

Criteria 

Inclusion Criteria:

Patients with ischemic cortical stroke in chronic stage (≥ 3 months) with residual motor deficits confirmed by imaging with brain CT scan and/or brain MRI

Informed consent

Exclusion Criteria:

Neurological issue:

inability to understand the informed consent form
Hemiplegia

Hyperbaric issue:

Claustrophobia
inability to put on face mask
uncontrolled epilepsy
dementia or psychological disturbance
previous pneumothorax
pregnancy
No Results Posted